Relation between Stress Hyperglycemia and Mortality in Patients with Acute Myocardial Infarction
Objectives: Acute myocardial infarction (AMI) is one of the leading causes of death in industrialized countries. Hyperglycemia and impaired glucose tolerance are common during AMI. We aimed to investigate the effect of stress (acute) hyperglycemia on mortality in patients with AMI who were not previously diagnosed with diabetes mellitus (DM).
Methods: We retrospectively reviewed 307 patients with acute coronary syndrome (ACS) who were admitted to the Emergency Department of Batman Regional State Hospital between January 1, 2014 and January 1, 2018. Stress hyperglycemia was considered to be present in patients with no DM history with a blood glucose level of >140 mg/dL or who had an HbA1c value of <6.5 in the last 3 months.
Results: Of the 307 patients in our study, 211 (68%) were male and 96 (32%) were female. Stress hyperglycemia was detected in 141 (45.9%) of the patients. It was found that 69% of patients with stress-related hyperglycemia had ST segment elevation myocardial infarction (STEMI) and 31% had non-ST segment elevation myocardial infarction (NSTEMI). We found that the rate of STEMI detection in patients with stress hyperglycemia was statistically significantly higher than that in NSTEMI (p<0.001). We found a significant relationship between the duration of hospital stay and hyperglycemia compared with the duration of hospitalization with stress hyperglycemia (p=0.01). In total, 24 patients (7.8%) died. Stress hyperglycemia was present in 66.1% of patients with exclusion, whereas 33.9% of patients did not have stress hyperglycemia. We found a statistically significant relationship between exclusion patients and stress hyperglycemia (p=0.002).
Conclusion: We found a significant association between stress hyperglycemia and mortality and duration of hospital stay in patients with AMI. We believe that prognosis and mortality of patients with AMI can be predicted using blood sugar level at the time of admission.
1. Onat A, Dursunoğlu D, Kahraman G, Ökçün B, Dönmez K, Keleş İ, et al. Rates of Death and of Coronary Events in the Turkish Adult Survey: 5-year Follow-up of the Cohort. [Article in Turkish]. Turk Kardiyol Dern Ars 1996;24:8–15.
2. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004;164:982–8. [CrossRef]
3. Kurtul A. What is Pathophysiology in Myocardial Infarction? What are the Clinical Signs? [Article in Turkish]. Turkiye Klinikleri J Cardiol-Special Topics 2009;2:1–6.
4. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes. Association Consensus Statement On Inpatient Glycemic Control. Endocr Pract 2009;15:353–69. [CrossRef]
5. Wagner GS, Macfarlane P, Wellens H, Josephson M, Gorgels A, Mirvis DM, et al; American Heart Association Electrocar diography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009;53:1003–11. [CrossRef]
6. Ürkmez S. Sepsiste kan şekeri kontrolü. Güncel Bilgiler Işığında Sepsis Sempozyum Dizisi. İstanbul-Türkiye, 30-31 Mayıs 2006: 89-97.
7. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986;293:917–22. [CrossRef]
8. Celik T, Iyisoy A, Turhan H, Isik E. Transient hyperglycemia in patients with acute myocardial infarction: time to define optimal glucose levels. Int J Cardiol 2008;130:472–3. [CrossRef]
9. Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: Role of insulin in glycemic control. AACN Clin Issues 2004;15:45–62. [CrossRef]
10. World Health Organization. Deaths from coronary heart disease. Available at: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_14_deathHD.pdf. Accessed Apr 18, 2018.
11. T.C. Sağlık Bakanlığı. Türkiye Kalp Ve Damar Hastalıklarını Önleme Ve Kontrol Programı; Risk Faktörlerine Yönelik Stratejik Plan ve Eylem Planı. Ankara 2008. Available at: http://file.tkd.org.tr/pdfscop/turkiye_kalp_ve_damar_hastaliklarini_onleme_ve_kontrol_programi.pdf, Accessed Apr 18, 2018.
12. Goldberger E, Alesio J, Woll F. The significance of hyperglycemia in myocardial infarction. New York State J Med 1945;45:391–3.
13. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626–32. [CrossRef]
14. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681–7. [CrossRef]
15. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002;51:1938–48. [CrossRef]
16. Altındal Ş. Diyabetik olmayan hipertansif hastalarda insülin direnci. [Uzmanlık tezi]. İstanbul: Okmeydanı Eğitim ve Araştırma Hastanesi; 2006.
17. Juhan-Vague I, Alessi MC. Fibrinolysis and risk of coronary artery disease. Fibrinolysis 1996;10:127–36. [CrossRef]
18. Kohler HP. Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med Wkly 2002;132:241–52
19. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003;89:512–6. [CrossRef]
20. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1144.